97 related articles for article (PubMed ID: 31151431)
1. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.
Yang Y; Huang X; Zhou L; Deng T; Ning T; Liu R; Zhang L; Bai M; Zhang H; Li H; Ba Y
BMC Cancer; 2019 May; 19(1):526. PubMed ID: 31151431
[TBL] [Abstract][Full Text] [Related]
2. Serum level of cytokeratin 19 fragment (CYFRA 21-1) indicates tumour stage and prognosis of squamous cell carcinoma of the oesophagus.
Tsuchiya Y; Onda M; Miyashita M; Sasajima K
Med Oncol; 1999 Apr; 16(1):31-7. PubMed ID: 10382940
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Serum SCC Antigen in the 566 Upfront Surgery Group of Esophageal Squamous Cell Carcinoma: A Multi-Institutional Study of the Japan Esophageal Society.
Suzuki T; Yajima S; Okamura A; Yoshida N; Taniyama Y; Murakami K; Ohkura Y; Nakajima Y; Yagi K; Fukuda T; Ogawa R; Hoshino I; Kunisaki C; Narumiya K; Tsubosa Y; Yamada K; Shimada H
Ann Thorac Cardiovasc Surg; 2024; 30(1):. PubMed ID: 38583987
[TBL] [Abstract][Full Text] [Related]
4. Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy.
Zhang LK; Zheng HL; Zheng HH; Ma YB; Lin JX; Xu BB; Xue Z; Zheng ZW; Zheng CH; Huang CM; Xie JW
Eur J Surg Oncol; 2024 Jun; 50(6):108367. PubMed ID: 38718701
[TBL] [Abstract][Full Text] [Related]
5. Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer.
Wang R; Xu B; Sun M; Pang X; Wang X; Zhu J; Lian J; Lu H
Eur J Surg Oncol; 2023 Dec; 49(12):107138. PubMed ID: 37925830
[TBL] [Abstract][Full Text] [Related]
6. Identifying intense inflammatory subtype of esophageal squamous cell carcinoma using clustering approach.
Matsuda S; Hoshino S; Goto T; Kawakubo H; Takeuchi M; Kobayashi R; Nakamura K; Takeuchi H; Nishihara H; Kitagawa Y
Gen Thorac Cardiovasc Surg; 2024 Jun; 72(6):417-425. PubMed ID: 38294659
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinical significance of tumor-associated macrophages in esophageal squamous cell carcinoma after surgery: do biomarkers and distributions matter?
Yi B; Zeng J; Li L; Zhang J; Chen Y; Gao Y
Biosci Rep; 2024 Apr; 44(4):. PubMed ID: 38501293
[TBL] [Abstract][Full Text] [Related]
8. Value of blood oxygenation level-dependent magnetic resonance imaging in early evaluation of the response and prognosis of esophageal squamous cell carcinoma treated with definitive chemoradiotherapy: a preliminary study.
Zheng H; Zhang H; Zhu Y; Wei X; Liu S; Ren W
BMC Med Imaging; 2024 Jan; 24(1):18. PubMed ID: 38216885
[TBL] [Abstract][Full Text] [Related]
9. Surgical outcomes and survival following esophagectomy for squamous cell carcinoma with or without liver cirrhosis: retrospective cohort study.
Park SY; Shin J; Jeon YJ; Lee J; Cho JH; Kim HK; Choi YS; Zo JI; Shim YM
Int J Surg; 2024 May; 110(5):2894-2901. PubMed ID: 38349217
[TBL] [Abstract][Full Text] [Related]
10. Squamous Cell Carcinoma Antigen in the Follow-up of Patients With Head and Neck Cancer.
Schepens EJA; Al-Mamgani A; Karssemakers LHE; van den Broek D; van den Brekel MWM; Lopez-Yurda M
Otolaryngol Head Neck Surg; 2024 Feb; 170(2):422-430. PubMed ID: 37694613
[TBL] [Abstract][Full Text] [Related]
11. Development of a Novel Prognostic Model for Esophageal Squamous Cell Carcinoma: Insights into Immune Cell Interactions and Drug Sensitivity.
Wang P; Liu Y; Wei L; Wang J; Wang J; Du B
Cancer Invest; 2024 Mar; 42(3):243-259. PubMed ID: 38616306
[TBL] [Abstract][Full Text] [Related]
12. Plasma-based lipidomics reveals potential diagnostic biomarkers for esophageal squamous cell carcinoma: a retrospective study.
Chen Y; Gu Y; Rong J; Xu L; Huang X; Zhu J; Chen Z; Mao W
PeerJ; 2024; 12():e17272. PubMed ID: 38699187
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Combination of Lymphocyte-to-Monocyte-Ratio and CYFRA 21-1 in Esophageal Squamous Cell Carcinoma.
Yang Y; Liu Z; Jiang C; Pan J; Yu B; Zhu K; Xu Y; Li Z
World J Surg; 2023 Dec; 47(12):3240-3249. PubMed ID: 37792039
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab.
Ikoma T; Shimokawa M; Matsumoto T; Boku S; Yasuda T; Shibata N; Kurioka Y; Takatani M; Nobuhisa T; Namikawa T; Kitagawa H; Hanazaki K; Doi K; Shimada T; Tsumura T; Marusawa H; Kanaya S; Morita S; Inokuma T; Nagai H; Yasui H; Satake H
Cancer Immunol Immunother; 2023 Feb; 72(2):427-435. PubMed ID: 35927359
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.
Chen M; Huang J; Zhu Z; Zhang J; Li K
BMC Cancer; 2013 Nov; 13():539. PubMed ID: 24206575
[TBL] [Abstract][Full Text] [Related]
16. Effect of blood type on survival of Chinese patients with esophageal squamous cell carcinoma.
Qin J; Wu SG; Sun JY; Lin HX; He ZY; Li Q
Onco Targets Ther; 2015; 8():947-53. PubMed ID: 25960667
[TBL] [Abstract][Full Text] [Related]
17. Brain metastasis from esophageal squamous cell carcinoma: a clinical review of 30 cases.
Yang Y; Yang Y; Wu X; Wang N; Zhang M
Neoplasma; 2023 Oct; 70(5):. PubMed ID: 38053381
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of LY6K and CDCA1 expression for patients with esophageal squamous cell carcinoma.
Oguma J; Ozawa S; Sakakibara T; Kajiwara H; Nakamura N; Makuuchi H
Ann Gastroenterol Surg; 2021 Mar; 5(2):194-203. PubMed ID: 33860139
[TBL] [Abstract][Full Text] [Related]
19. Molecular characteristics and multivariate survival analysis of 43 patients with locally advanced or metastatic esophageal squamous cell carcinoma.
Zhou X; Bao W; Zhu X; Wang D; Zeng P; Xia G; Xing M; Zhan Y; Yan J; Yuan M; Zhao Q
J Thorac Dis; 2024 Mar; 16(3):1843-1853. PubMed ID: 38617776
[TBL] [Abstract][Full Text] [Related]
20. In silico analyses of pan-squamous cell carcinoma unveiled the immunological implications of MRPL13, which had previously been under-recognized.
Liang Y; He S; Tan Y; Liu Q; Zhao F; Liu T; Huang C; Lu X; Zheng S
Heliyon; 2024 Jan; 10(1):e23582. PubMed ID: 38187248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
